Imitrex Injection Articles
FDA accepts Spectrum's ANDA for cancer drug
1 August 2005
US ANDA filings "buy time for branded drugs"
24 January 2005
FDA accepts Spectrum's sumatriptan ANDA
17 January 2005
UK FIRMS BOOSTED BY YEAR-END US APPROVALS
4 January 1993
Showing 1-4 of 4 articles
- 1
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
